Katrin Mani
21 – 30 of 70
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Xyloside-primed chondroitin sulfate/dermatan sulfate from breast carcinoma cells with a defined disaccharide composition has cytotoxic effects in vitro
(
- Contribution to journal › Article
- 2015
-
Mark
Rapid nuclear transit and impaired degradation of amyloid beta and glypican-1-derived heparan sulfate in Tg2576 mouse fibroblasts.
(
- Contribution to journal › Article
-
Mark
Suppression of glypican-1 autodegradation by NO-deprivation correlates with nuclear accumulation of amyloid beta in normal fibroblasts.
(
- Contribution to journal › Article
-
Mark
Exploration of the active site of β4GalT7: modifications of the aglycon of aromatic xylosides.
(
- Contribution to journal › Article
-
Mark
Structural aspects of N-glycosylations and the C-terminal region in human glypican-1.
(
- Contribution to journal › Article
- 2014
-
Mark
Rules for priming and inhibition of glycosaminoglycan biosynthesis; probing the beta 4GalT7 active site
(
- Contribution to journal › Article
-
Mark
APP/APLP2 expression is required to initiate endosome-nucleus-autophagosome trafficking of glypican-1-derived heparan sulfate.
(
- Contribution to journal › Article
-
Mark
GPC1 (glypican 1)
(
- Contribution to journal › Article
- 2013
-
Mark
Non-toxic amyloid beta formed in the presence of glypican-1 or its deaminatively generated heparan sulfate degradation products
(
- Contribution to journal › Article
-
Mark
Synthesis and biology of oligoethylene glycol linked naphthoxylosides.
(
- Contribution to journal › Article